跳至主導覽 跳至搜尋 跳過主要內容

Hepatitis B flare: the good, the bad and the ugly

研究成果: 期刊稿件 › 文獻綜述 › 同儕審查

15 引文 斯高帕斯(Scopus)

摘要

Introduction: Hepatitis B flare, defined as an event of abrupt ALT elevation to >5x ULN, is a frequent episode during the natural course or during/after antiviral therapy of chronic HBV infection, in both HBeAg-positive and HBeAg-negative patients with chronic hepatitis B or liver cirrhosis. Areas covered: The definition, pathogenesis, clinical presentation, and management of hepatitis B flares in the published literature were reviewed. Hepatitis B flares have been considered as a result of the robust immune response of the patient to an upsurging HBV/HBV-antigen(s). ‘Host-dominating flares,’ reflect effective immune response, may resolve with ALT normalization and decline of HBV/ antigen(s). Contradictorily, ‘virus-dominating flares,’ reflect ineffective immune response, are usually followed by persistent/intermittent hepatitis and may even develop hepatic decompensation/failure. Expert opinion: Not all hepatitis B flares require antiviral therapy, and close observation with combined HBsAg/ALT kinetics along the ascending ALT during hepatitis flare may differentiate hepatitis flares for an appropriate treatment/retreatment decision. More studies are needed to verify this proposal. Further immunologic studies using multiple samples during hepatitis B flare are important to clarify the precise underlying mechanisms as the basis for further improvement in the management of hepatitis flare.

原文英語
頁(從 - 到)1043-1051
頁數9
期刊Expert Review of Gastroenterology and Hepatology
卷16
發行號11-12
DOIs
出版品狀態已出版 - 2022

文獻附註

Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Hepatitis B flare: the good, the bad and the ugly」主題。共同形成了獨特的指紋。

引用此